EUVIMEDEUVIMED entdecken
Crossref

Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility

Alex J Adams

Journal of the American Pharmacists Association · 2026-11 · 66 (6) · 103522

DOI: 10.1016/j.japh.2026.103522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-11. Verfasst von Alex J Adams. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Pharmacists, Health Services Accessibility, Community Pharmacy Services. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioid use disorder (OUD) is a treatable chronic disease, yet access to medications for OUD remains uneven, particularly in rural and underserved communities where prescriber shortages, travel burdens, and restrictive scope-of-practice laws can delay care. Community pharmacists are highly accessible medication experts who already monitor therapy, counsel patients, identify safety concerns, and coordinate care. States should consider authorizing pharmacists to initiate or prescribe medications for OUD, consistent with federal authority and established standards of care. Pharmacy-based care models suggest that this approach can shorten treatment delays and strengthen continuity while supporting individualized care throughout recovery. Expanded pharmacist authority also has implications beyond health care: untreated parental OUD contributes to child welfare involvement, and timely treatment can help stabilize families and prevent unnecessary separation. Recent federal guidance, Title IV-E financing pathways, and the Rural Health Transformation Program give states tools to align pharmacy regulation, Medicaid payment, behavioral health systems, and child welfare policy. Removing unnecessary barriers to pharmacist prescribing could expand the treatment workforce, improve access close to home, and make evidence-based care available when patients are ready to begin recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersPharmacistsHealth Services AccessibilityCommunity Pharmacy ServicesScope of PracticeAnalgesics, OpioidHumansUnited StatesProfessional RoleNon-Medical Prescribing

Substanzen

Analgesics, Opioid

Zitieren

APA

Adams, A. J. (2026). Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility. Journal of the American Pharmacists Association, 66(6), 103522. https://doi.org/10.1016/j.japh.2026.103522

Vancouver

Adams AJ. Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility. Journal of the American Pharmacists Association. 2026;66(6):103522. doi:10.1016/j.japh.2026.103522

BibTeX
@article{Adams2026,
  author = {Adams, Alex J},
  title = {Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility},
  journal = {Journal of the American Pharmacists Association},
  year = {2026},
  volume = {66},
  number = {6},
  pages = {103522},
  doi = {10.1016/j.japh.2026.103522}
}
Kostenlos starten →